1. 1,3-Oxazine-2-one derived dual-targeted molecules against replicating and non-replicating forms of Mycobacterium tuberculosis.
- Author
-
Velappan AB, Kesamsetty D, Datta D, Ma R, Hari N, Franzblau SG, and Debnath J
- Subjects
- Antitubercular Agents chemical synthesis, Antitubercular Agents toxicity, Bacterial Proteins antagonists & inhibitors, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors pharmacology, Enzyme Inhibitors toxicity, Leukocytes, Mononuclear drug effects, Methyltransferases antagonists & inhibitors, Microbial Sensitivity Tests, Molecular Structure, Mycobacterium smegmatis drug effects, Mycolic Acids metabolism, Oxazines chemical synthesis, Oxazines toxicity, Structure-Activity Relationship, Antitubercular Agents pharmacology, Mycobacterium tuberculosis drug effects, Oxazines pharmacology
- Abstract
The high mortality rate and increasing prevalence of resistant Mtb are the major concerns for the Tuberculosis (TB) treatment in this century. To curtail the prevalence of resistant Mtb, we have prepared 1,3-oxazine-2-one based dual targeted molecules. Compound 67 and 68 were found to be equally active against replicating and non-replicatiing form of Mtb (MIC
MABA 3.48 and 2.97 μg/ml; MICLORA 2.94 and 2.15 μg/ml respectively). They had found to suppress the biosynthesis of alfa, methoxy and keto-mycolate completely, as well as inhibit enzymatic activity of MenG (IC50 = 9.11 and 6.25 μg/ml respectively for H37Ra; IC50 = 11.76 and 10.88 μg/ml respectively for M smegmatis)., Competing Interests: Declaration of competing interest There is no conflict of interest with others., (Copyright © 2020 Elsevier Masson SAS. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF